On August 26, 2026 Odyssey Therapeutics, Inc. (Nasdaq: ODTX) ("Odyssey" or the "Company"), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that precisely target disease pathology, reported that members of its management team will participate in the following upcoming investor conferences in September:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2026 Cantor Global Healthcare Conference
Conference Dates: September 9-11, 2026
Location: New York, NY
Fireside Chat: September 9th at 8:35AM ET
Morgan Stanley 24th Annual Global Healthcare Conference
Conference Dates: September 14-16, 2026
Location: New York, NY
Fireside Chat: September 14th at 10:45AM ET
H.C. Wainwright 28th Annual Global Investment Conference
Conference Dates: September 14-16, 2026
Location: New York, NY
Fireside Chat: September 15th at 1:00PM ET

Where available, live webcasts will be available under "News and Events" in the Investors section of the Company’s website at www.odysseytx.com. Replays of the webcasts will be made available on the Events page of Odyssey’s investor website and archived for 60 days.

(Press release, Odyssey Therapeutics, AUG 26, 2026, View Source [SID1234670348])